Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

We have made great strides in the medical community, with people having access to life-saving physical drugs as well as ...

If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...

The U.S. Food and Drug Administration has approved a nasal spray to treat depression—the first-ever stand-alone medication for patients with severe depression. Johnson & Johnson said patients who use ...

Many with ADHD report that medication — typically a stimulant but treatment can also include non-stimulants and ...

The government states on its website that the DVLA must be informed if your depression is severe and affects your ability to ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

Drivers have been warned conditions such as depression and anxiety can significantly affect concentration, reaction times, ...

According to experts, drivers should also inform their car insurance provider of their condition as failing to do so may ...

The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...